Huntsman, BASF and Chinese Companies Consider Construction of New MDI Plant in China

Huntsman Corporation, BASF and a group of Chinese companies -- Shanghai Hua Yi, Sinopec Shanghai Gao Qiao Petrochemical Corporation and Shanghai Chloro-Alkali Chemical Co. Ltd -- are considering the construction of a new MDI (diphenylmethane diisocyanate) plant in China to meet growing demand for this product. Several sites for the plant are being evaluated. The startup is planned from 2010 onward, and the plant is expected to have a capacity of 400,000 metric tons per year of crude MDI, to be sold and marketed separately by Huntsman and BASF.

"The market for polyurethanes in China is growing at double-digit rates and this is expected to continue well into the next decade," says Tony Hankins, President of Huntsman's Polyurethanes division. "We are a leading player in this dynamic market and the proposed investment will complement our new MDI facility in Caojing, strengthening our ability to serve customers through local production".

MDI is an important precursor in the manufacture of polyurethanes -- versatile polymers that are used in the automotive and construction industries, in appliances such as refrigerators, and for footwear.

As part of Huntsman's investment strategy for the Chinese market, an integrated isocyanates complex is currently under construction at the Shanghai Chemical Industry Park in Caojing. This project is progressing as scheduled, and is expected to begin commercial production by mid-2006. The complex is also a production joint venture between Huntsman, BASF and the same group of Chinese companies mentioned above. It will have a capacity of 240,000 metric tons per year of crude MDI. The total cost for the complex is about $1 billion.

http://www.huntsman.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.